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ABSTRACT
Objectives Readmission and death are frequent after 
a hospitalisation and difficult to predict. While many 
predictors have been identified, few studies have focused 
on functional status. We assessed whether performance-
based functional impairment at discharge is associated 
with readmission and death after an acute medical 
hospitalisation.
Design, setting and participants We prospectively 
included patients aged ≥50 years admitted to the 
Department of General Internal Medicine of a large 
community hospital. Functional status was assessed 
shortly before discharge using the Timed Up and Go 
test performed twice in a standard way by trained 
physiotherapists and was defined as a test duration ≥15 s. 
Sensitivity analyses using a cut-off at >10 and >20 s were 
performed.
Primary and secondary outcome measures The 
primary and secondary outcome measures were 
unplanned readmission and death, respectively, within 6 
months after discharge.
Results Within 6 months after discharge, 107/338 
(31.7%) patients had an unplanned readmission and 
31/338 (9.2%) died. Functional impairment was associated 
with higher risk of death (OR 2.44, 95% CI 1.15 to 5.18), 
but not with unplanned readmission (OR 1.34, 95% CI 0.84 
to 2.15). No significant association was found between 
functional impairment and the total number of unplanned 
readmissions (adjusted OR 1.59, 95% CI 0.95 to 2.67).
Conclusions Functional impairment at discharge of an 
acute medical hospitalisation was associated with higher 
risk of death, but not of unplanned readmission within 
6 months after discharge. Simple performance-based 
assessment may represent a better prognostic measure 
for mortality than for readmission.
InTRODuCTIOn
After an acute care hospitalisation, read-
missions are frequent, affecting 14%–22% 
of the patients within 30 days after hospital 
discharge, and are associated with signifi-
cant costs as well for the patients themselves 
as for the healthcare systems.1–3 Factors that 
contribute to readmission are manifolds, 
including multimorbidity, complication of 
medical treatment, length of hospital stay, 
number of previous hospitalisations, socioeco-
nomic factors, care coordination, monitoring, 
follow-up care and/or home support.1 4 5 In 
this complex equation, patient’s functional 
impairment could intuitively be considered 
as a potential predictor for readmission, as it 
may capture overall health status, including 
cardiorespiratory reserve and risk of falls alto-
gether.6 7
Few studies assessed the association 
between performance-based functional 
impairment and readmission.8–16 Although 
those studies reported mainly a significant 
association between functional impairment 
and readmission, they were often limited 
by a retrospective design, or by focusing on 
a specific setting such as surgical ward or 
rehabilitation care facilities or on specific 
populations such as older adults or patients 
with chronic obstructive pulmonary disease 
or myocardial infarction. Functional impair-
ment has also been associated with mortality 
in several studies in ambulatory care 
settings,16–25 while the few studies assessing 
this outcome after a hospitalisation found 
controversial results.12 14 26
Performance-based functional methods 
have been shown to perform better than 
self-reported assessment.27 One of the 
former is the Timed Up and Go (TUG) test, 
a brief, objective and simple assessment of 
functional status that does not require any 
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Strengths and limitations of this study
 ► Large prospective cohort study evaluating the 
association of performance-based assessment 
with readmissions and death in medical inpatients 
aged ≥50 years.
 ► Long follow-up time of 6 months without loss to 
follow-up.
 ► Assessment of both readmissions and deaths, 
separately.
 ► Single-centre study including only medical patients.
group.bmj.com on February 19, 2018 - Published by http://bmjopen.bmj.com/Downloaded from 
2 Aubert CE, et al. BMJ Open 2017;7:e016207. doi:10.1136/bmjopen-2017-016207
Open Access 
special competence or equipment, allowing a wide use in 
everyday practice.28 Unlike many tools to assess functional 
status, the TUG test gives information on both balance 
and cardiorespiratory capacity, and it was associated 
with overall health decline.6 It has been also shown not 
to suffer from ceiling effect limitations and to be related 
to executive function.29 These characteristics make it a 
good potential tool to assess the risk of readmission. We 
therefore hypothesised that the TUG test may be a good 
predictor of adverse health outcomes, such as readmis-
sion.
In summary, although the TUG test has been associated 
with death and to a lesser extent with readmission, few 
studies looked at the predictability of the TUG test in a 
broader population such as general medical inpatients. 
Our aim was therefore to assess the association of perfor-
mance-based functional impairment at discharge of an 
acute medical hospitalisation with unplanned readmis-
sion and death in a prospective cohort study including 
medical patients aged 50 years or older.
MATeRIAlS AnD MeThODS
Reporting is in accordance with the STrengthening the 
Reporting of OBservational studies in Epidemiology (STROBE) 
statement.30
Study design and population
In a prospective cohort study, we included all consecu-
tive patients aged ≥50 years admitted to the Department 
of General Internal Medicine of a large secondary care 
hospital in Switzerland (Fribourg Cantonal Hospital, 
115 beds, 4400 admissions per year), between April and 
September 2013. Our exclusion criteria were as follows: 
(1) discharge the day of admission; (2) discharge to 
another acute care clinic, a rehabilitation setting, a palli-
ative care clinic or another division of the same hospital; 
(3) death during the index hospitalisation; and (4) 
refusal or inability to give informed consent. The study 
complies with the Declaration of Helsinki and local 
ethics committee (Commission d’Éthique de Recherche, 
Direction de la Santé et des Affaires Sociales, Fribourg, 
Switzerland) approved the study. For this observational 
cohort without intervention, we did not perform a sample 
size calculation, and we limited the sample size due to the 
resources available.
Outcomes
We defined our primary outcome as the first unplanned 
readmission to any division of any acute care hospital and 
our secondary outcome as death, both within 6 months 
after discharge of index hospitalisation. We defined 
planned readmission as scheduled hospitalisation for 
investigation (eg, elective bronchoscopy) or for not emer-
gent treatment (eg, planned radiotherapy for oncological 
treatment). All patients were contacted by phone call 6 
months after discharge in order to record our outcomes. 
If we failed to reach the patient directly, we phoned the 
general practitioner, a next of kin or the nursing home, 
depending on each situation. To increase reliability, we 
additionally checked in the electronic health record for 
any readmission or death recorded within the network of 
Fribourg hospitals, which includes the three acute care 
hospitals of the same region (Fribourg, Riaz and Tavel) 
and four rehabilitation centres (Billens, Murten, Riaz and 
Tavel).
Functional status assessment
Patients performed the TUG test before discharge, 
according to its original description.28 They were 
instructed to stand up from a chair without using their 
arms, walk 3 m ahead (distance was marked on the floor), 
turn around, walk back to the chair and sit down. The 
duration to complete the test was timed by a stopwatch 
and recorded in seconds, beginning on the command 
‘go’ given to the patient and ending after he/she had sit 
down and leaned against the back of the chair. The test 
was performed twice and the shortest time, indicating 
the best performance, was used for the analyses. Patients 
were allowed to use routine walking aids if needed (eg, 
crutches or walker), but they did not receive any physical 
assistance. Only three different trained physiotherapists 
performed the TUG test to all the cohort population. 
Patients who were too debilitated to perform the test were 
classified as having functional impairment.
We decided to dichotomize the results of the TUG test 
instead of using it as a continuous variable or in a higher 
number of categories because we thought that classifying 
patients at high versus low risk of readmission or death 
would be more useful to interpret for clinicians. As we 
found no agreement in the literature for a specific dura-
tion to sort out patients with functional impairment,7 we 
used the receiver operating characteristic (ROC) curve 
to define the optimal cut-off level associated with our 
outcomes. For this purpose, we used the point closest to 
the top left corner of the ROC curve because it represents 
the best compromise between sensitivity and specificity.31 
Functional impairment was defined as a TUG test duration 
longer than the cut-off level that we identified. The areas 
under the ROC curves were 0.57 (95% CI 0.51 to 0.64) for 
6 month unplanned readmission and 0.63 (95% CI 0.54 
to 0.73) for 6 month death. Both ROC curves identified 
the optimal cut-off level at 15 s. At this cut-off level, the 
sensitivity was 39.2% and 58.1% for unplanned readmis-
sion and death, respectively, and the specificity was 66.1% 
and 64.1%, respectively.
Covariates
Sociodemographic data, number of hospitalisations 
during the 6 months before index admission and clin-
ical information were recorded at baseline. Comorbidity 
was assessed by the Charlson comorbidity index, which 
attributes a number of points of 1, 2, 3 or 6 to different 
medical conditions, depending on their severity,32 and 
multimorbidity was defined as the presence of at least two 
chronic diseases according to this index. The main diag-
noses of index admission were retrieved from medical 
records and divided into 10 categories, according to the 
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Figure 1 Study flow diagram. TUG, Timed Up and Go.
system affected: (1) osteoarticular disease, (2) gastro-
intestinal disease, (3) infection, (4) neuropsychiatric 
disease (including dementia, alcohol disorder and intox-
ication), (5) respiratory disease, (6) oncological disease, 
(7) endocrine or metabolic disease, (8) renal disease, (9) 
cardiovascular disease and (10) other.
Data analysis
We presented continuous variables as median with 
IQR because of their non-normal distribution, and 
we compared them using non-parametric K-sample test 
on the equality of medians. Categorical variables were 
presented as frequency and percentage and compared 
using Pearson’s χ2 test.
Univariate logistic regression analysis was used to assess 
the association between functional impairment and 
unplanned readmission and death, respectively, within 
6 months after hospital discharge. Multivariate analysis 
was adjusted for age and gender. A collinearity diag-
nostic measurement was performed to detect collinearity 
between the variables included in the model.33 A link test 
was used to confirm that the linear approach to model 
the outcome was correct.34 We used age as a continuous 
variable because assessing the variable in categories or 
after cubic or quadratic transformation yielded similar 
results. Model fit was assessed using the Hosmer-Leme-
show goodness-of-fit test.35
We performed two sensitivity analyses including eight 
patients with missing data for the TUG test. We defined 
the duration of their non-performed TUG test as ≥15 s in 
the first one (ie, functional impairment) and as <15 s in the 
second one (ie, no functional impairment). As there was 
no agreement for a specific cut-off when dichotomizing 
the TUG test duration,7 although we used a validated 
method to select it,31 we also performed additional 
sensitivity analyses with the cut-off set at >10 and>20 s, 
respectively, as done in previous studies.12 14 22 We finally 
performed a sensitivity analysis excluding the patients 
who were too debilitated to perform the test. A two-sided 
p<0.05 was considered to indicate statistical significance. 
All analyses were performed using STATA release 13.0 
(StataCorp, College Station, Texas, USA).
ReSulTS
We included 338 patients (figure 1) and had no lost to 
follow-up, as we managed to get the outcome informa-
tion per phone call (to the patient or to the general 
practitioner, a next of kin or the nursing home) for all 
patients. Median age was 73 (IQR 65–83) years with 168 
(49.7%) men. Median Charlson comorbidity index was 5 
(IQR 7–9) and 302 (89.4%) of the patients had multimor-
bidity. Median length of stay for index hospitalisation was 
7 (IQR 4–12) days. Within 6 months after discharge, 107 
(31.7%) patients had an unplanned readmission and 31 
(9.2%) died. Among the 31 patients who died, 23 (74.2%) 
had been previously readmitted. Patients with functional 
impairment were older and more likely to be women and 
to have been admitted to hospital within the 6 months 
before index admission (p<0.003 for all). They had also a 
higher Charlson comorbidity index and a longer length 
of stay (p<0.001 for all). Cardiovascular, infectious and 
neuropsychiatric diseases were the three most frequent 
main diagnoses of index hospitalisation, with 91 (27%), 
67 (20%) and 65 (19%) cases, respectively.
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Table 1 Baseline characteristics according to the presence 
of 6 month readmission.
Variable
6 month 
readmission 
(n=107)
No 6 month 
readmission 
(n=231)
Age, years 72 (64–83) 74 (64–83)
Men 57 (53.3) 111 (48.1)
Charlson comorbidity index 8 (6–10) 6 (4–8)
Multimorbidity* 100 (93.5) 202 (87.5)
Previous admission† 51 (47.7) 44 (19.1)
Duration of TUG test, seconds 13 (10–19) 12 (8–18)
TUG test duration ≥15 s 46 (43.0) 83 (35.9)
Hospitalisation characteristics
  Elective 3 (2.8) 10 (4.3)
  Length of stay, days 9 (5–15) 6 (4–11)
Diagnosis of index admission
  Cardiovascular disease‡ 25 (23.4) 66 (28.6)
  Infection 20 (18.7) 47 (20.4)
  Neuropsychiatric disease§,¶ 17 (15.9) 48 (20.8)
  Oncological disease 16 (15.0) 10 (4.3)
  Respiratory disease§ 15 (14.0) 15 (6.5)
  Other 4 (3.8) 12 (5.2)
  Gastrointestinal disease§ 2 (1.9) 16 (6.9)
  Osteoarticular disease§ 4 (3.8) 6 (2.6)
  Endocrine or metabolic 
disease
3 (2.8) 8 (3.5)
  Renal disease 1 (0.9) 3 (1.3)
Data are n (% of column) or median (IQR).
*Two or more comorbidities as recorded in the Charlson 
comorbidity index.
†Hospital admission(s) during the 6 months preceding index 
admission.
‡Including ischemic/thrombotic disorder, congestive heart 
failure and arrhythmia.
§Other than infection.
¶Including dementia, alcohol disorder and intoxication.
Table 2 Baseline characteristics according to the presence 
of 6 month death.
Variable
6 month 
death 
(n=31)
No 6 month 
death 
(n=331)
Age, years 69 (64–80) 74 (65–83)
Men 15 (48.4) 153 (49.8)
Charlson comorbidity index 10 (7–12) 7 (5–9)
Multimorbidity* 28 (90.3) 274 (89.3)
Previous admission† 17 (54.8) 78 (25.4)
Duration of TUG test, seconds 17 (11–21) 12 (8–18)
TUG test duration ≥15 s 18 (58.0) 111 (36.2)‡
Hospitalisation characteristics
  Elective 0 (0.0) 13 (4.2)
  Length of stay, days 13 (6–27) 6 (4–11)
Diagnosis of index admission
  Cardiovascular disease‡ 3 (9.7) 88 (28.7)
  Infection 5 (16.1) 62 (20.2)
  Neuropsychiatric disease§, ¶ 2 (6.5) 63 (0.5)
  Oncological disease 12 (38.7) 14 (4.6)
  Respiratory disease§ 1 (3.2) 29 (9.5)
  Other 2 (6.5) 14 (4.6)
  Gastrointestinal disease§ 4 (12.9) 14 (4.6)
  Osteoarticular disease§ 0 (0.0) 10 (3.3)
  Endocrine or metabolic 
disease
1 (3.2) 10 (3.3)
  Renal disease§ 1 (3.2) 3 (1.0)
Data are n (% of column) or median (IQR).
*Two or more comorbidities as recorded in the Charlson 
comorbidity index.
†Hospital admission(s) during the 6 months preceding index 
admission.
‡Including ischemic/thrombotic disorder, congestive heart 
failure and arrhythmia.
§Other than infection.
¶Including dementia, alcohol disorder and intoxication.
Association of functional impairment with unplanned 
readmission and death
Table 1 and table 2 show the baseline characteristics 
according to the presence or absence of readmission or 
death, respectively. The median duration of the TUG 
test was 13 (IQR 10–19) s for patients with an unplanned 
readmission and 12 (IQR 8–18) s for those without any 
unplanned readmission (p=0.34). The TUG test duration 
was significantly longer among patients who died (median 
(IQR) duration: 17 (11–21) vs 12 (8–18) s, p=0.04). The 
duration of the TUG test was ≥15 s in 46 (43.0%) of the 
107 patients with an unplanned readmission as well as in 
18 (58.1%) of the patients who died within 6 months after 
hospital discharge.
Functional impairment was associated with a higher risk 
of death within 6 months after discharge (OR 2.44, 95% CI 
1.15 to 5.18), while the risk of unplanned readmission 
was not significantly increased (OR 1.34, 95% CI 0.84 to 
2.15). After adjusting for age and gender, the association 
was even stronger for death (OR 3.55, 95% CI 1.52 to 
8.25), but it remained unchanged for unplanned read-
mission (OR 1.58, 95% CI 0.94 to 2.64). We found no 
significant association between functional impairment 
and the absolute total number of unplanned readmis-
sions within 6 months (unadjusted OR 1.34, 95% CI 0.84 
to 2.15; adjusted OR 1.59, 95% CI 0.95 to 2.67). P-value 
for the Hosmer-Lemeshow goodness-of-fit test was >0.05 
for both adjusted models, indicating good fit. The vari-
ance inflation factors and tolerance were near 1.00 for 
all variables, excluding significant collinearity. The link 
test confirmed that the linear approach to model the 
outcomes was correct.
In both sensitivity analyses including the eight patients 
with missing data for the TUG test, results remained 
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similar, with a significant increased risk of death, but 
not of readmission: sensitivity analysis defining patients 
with missing data as functional impaired (TUG test dura-
tion ≥15 s): adjusted OR 3.57, 95% 1.57–8.08 for death, 
adjusted OR 1.77, 95% CI 1.07 to 2.92 for readmission; 
sensitivity analysis defining patients with missing data 
as non-functional impaired (TUG test duration <15 s): 
adjusted OR 2.93, 95% CI 1.31 to 6.56 for death, adjusted 
OR 1.43, 95% CI 0.86 to 2.37 for readmission. Results were 
similar in the sensitivity analyses setting the cut-off point 
at >10 or>20 s, respectively: OR 1.67 (95% CI 0.97 to 2.86) 
and 1.32 (95% CI 0.74 to 2.35) for readmission and OR 
2.69 (95% CI 1.09 to 6.67) and 2.64 (95% CI 1.11 to 6.30) 
for death, as well as in the sensitivity analysis excluding 
12 patients who were too debilitated to perform the TUG 
test (OR 4.16, 95% CI 1.76 to 9.83 for death; OR 1.50, 
95% CI 0.88 to 2.55 for readmission).
COnCluSIOn
In this prospective cohort study, we found that functional 
impairment, defined as ≥15 s to perform the validated 
performance-based ‘Timed Up and Go test’ before acute 
care hospital discharge, was associated with an almost 
150% increase in the risk of death within 6 months after 
hospital discharge. Conversely, functional impairment 
was not associated with an increased risk of unplanned 
readmission.
These findings contrast with previous studies in which 
functional impairment was mostly positively associated 
with a higher risk of readmission.8–13 Several reasons may 
explain this difference.
First, we used the TUG test, which has been largely 
validated as a simple, quick and reliable clinical method 
to assess functional status,28 36–40 and presents several 
advantages in comparison with other tools to assess func-
tional status. The TUG test is objective, and its very high 
inter-rater and test-retest reliability allows better compa-
rability than other tools.28 40 41 Although this measure is 
very simple, it is actually constituted of several complex 
sequences (eg, moving from the sitting to the standing 
position), each of which evaluating multiple aspects 
needed for adequate functional status, including balance, 
mobility, cardiorespiratory function and coordination.42 
It may therefore capture several factors such as disease 
severity, independently of the kind of disease, and may as 
such be a good proxy to predict overall health decline.6 7 
Moreover, as opposed to other tools used to assess func-
tional status,43–45 the TUG test does not suffer from ceiling 
or floor effects in healthy older adults.29 Furthermore, 
a physiotherapist is not absolutely needed, as it can be 
performed by nursing personal as well.46 47
Second, we included only patients discharged 
directly home or to a nursing home, while others 
focused on patients discharged to a rehabilitation care 
facility.8 Patients discharged to a rehabilitation clinic 
may be more functionally impaired and have a higher 
morbidity level than other patients at discharge from 
the acute care setting. Conversely, we can suppose that 
functional status will be improved by the rehabilitation 
stay, which may consequently lower the following risk 
of readmission or death. Similarly, other authors evalu-
ated functional status at admission before an elective 
operation, at the time of discharge from the emergency 
department or 1 month after discharge.11 15 16 We may 
suppose that all those patients have a better functional 
status than our population, as the acute care hospitalisa-
tion may affect functional status, limiting comparability 
with our study.
Third, we focused on medical patients aged 50 years or 
older, while others studied older adults9–12 15 or patients 
with a specific disease, such as chronic obstructive pulmo-
nary disease or myocardial infarction.11 13 Fourth and 
finally, we included only unplanned readmissions, while 
many previous studies included elective readmissions in 
the primary outcome.8 10–14 16 Two other findings in our 
study support the absence of association between func-
tional impairment and readmission. First, the number 
of hospitalisations in the 6 months following discharge 
was not significantly higher in the group of patients with 
functional impairment. Second, sensitivity analyses using 
other cut-off points to define functional impairment 
yielded similar results.
Interestingly, we found a significant association between 
functional impairment and death within 6 months after 
hospital discharge. Only few studies looked at this rela-
tionship between functional impairment and mortality 
following discharge.12 14 26 Two of them, which included 
135 geriatric and 495 medical inpatients, respectively, 
were negative,14 26 while another study using the TUG test 
in 147 geriatric inpatients found an association.12 Our 
results are consistent with studies performed in ambula-
tory care settings.16–24 All these findings together support 
that functional impairment may rather be a predictor for 
mortality than for readmission.
If confirmed by larger studies in general medical 
inpatients, our findings may have two main clinical impli-
cations. First, it may help to identify high-risk patients who 
would most likely benefit from interventions that have 
been shown to improve functional status.10 48 However, 
further studies are needed to assess if these interventions 
can improve patients’ outcome also. Second, it may help 
clinicians to assess the risk of short-term death of their 
patients and to consequently tailor preventive and ther-
apeutic care to each patient. Some drugs or preventive 
prescriptions, such as cancer screening, may indeed more 
harm than benefit to those high-risk patients unlikely to 
survive long enough to benefit from the intervention. 
The TUG test may, therefore, represent an easy-to-use 
and reliable tool for clinicians to improve assessment 
of patients’ life expectancy. As our results were similar 
when including or excluding patients who were too 
debilitated to perform the test, our findings may apply to 
those patients also, if classified as functionally impaired. 
Furthermore, our simple model adjusting only for age 
and gender lets suppose that other variables are not 
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needed to predict the risk of death, which may be useful 
for clinical implementation.
Our findings should be considered in light of some 
limitations. First, our sample was relatively small. Second, 
the study was conducted in a single centre and included 
only medical patients, limiting the generalizability of our 
results; however, except for age, our population was other-
wise unselected. Third, we excluded patients who were 
discharged to a rehabilitation facility because we hypothe-
sised that their functional status at discharge of the acute 
care setting would not reflect their actual functional status 
at discharge of the rehabilitation clinic. Our findings may 
therefore not apply to these patients. Fourth, although we 
may not exclude residual confounding factors, the aim of 
our study was to evaluate the performance of the TUG 
test as a simple overall prediction measure and not as an 
independent risk factor. Therefore, we adjusted only for 
age and gender.
Our study has some strengths. First, we studied both 
readmissions and deaths, separately. Second, it was a 
prospective study with a long follow-up time of 6 months 
and no loss to follow-up during this whole period. Third, 
we included only unplanned readmissions. Fourth, we 
had no lost to follow-up, very few missing data, and in the 
sensitivity analyses including patients with missing data, 
excluding patients unable to perform the test or using 
other cut-off points to define functional impairment, 
results remained unchanged.
In conclusion, in this prospective cohort study, func-
tional impairment was associated with an increased 
risk of death within 6 months after hospital discharge, 
but not with a significant risk of readmission. Simple 
performance-based assessment may represent a better 
prognostic measure for mortality than for readmission.
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